Live Breaking News & Updates on Fudan university affiliated huashan hospital

Stay informed with the latest breaking news from Fudan university affiliated huashan hospital on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Fudan university affiliated huashan hospital and stay connected to the pulse of your community

Regular consumption of tea found to reduce risk of dementia and improve cognitive function

Dementia is characterized by symptoms like memory loss and impaired judgment. Once considered a disease primarily affecting the elderly, many people under the age of 65 are now getting diagnosed [...]

United-kingdom , Switzerland , Brussels , Bruxelles-capitale , Belgium , Swiss , Natural-news , Fudan-university-affiliated-huashan-hospital , Frozen-in-time , Alzheimers-disease , Dementia

Study Confirms Drinking Tea Can Improve Cognitive Function

Characterized by symptoms including memory loss and hindered judgment, dementia is a common condition that can affect daily ...

Japan , Japanese , Translational-psychiatry , Fudan-university-affiliated-huashan-hospital , Epoch-times , Cognitive-dysfunction , Dementia , Tea , The-epoch-times ,

Half of China's 1.4 billion people projected to get COVID-19 | The Asahi Shimbun: Breaking News, Japan News and Analysis

BEIJING--Half of China’s 1.4 billion people will be infected by the novel coronavirus in the coming months, analysts said, based on trends seen after the government eased its “zero COVID-19” policy earlier this month.

Japan , Tokyo , Shanghai , China , United-states , Hong-kong , Zhejiang , Kitasato , Japan-general- , Beijing , Wuhan , Hubei

China NMPA Approves NUZYRA® as a Category 1 Innovative Drug

NUZYRA demonstrated efficacy against common pathogens in three Phase 3 studies, including pathogens resistant to other antibiotic classes as a potential...

Shanghai , China , Taiwan , United-states , Hong-kong , Jing-zhang , Henan , Cambridge , Cambridgeshire , United-kingdom , Macau , Chinese

China NMPA Approves NUZYRA® as a Category 1 Innovative Drug for the Treatment of Patients with ...

NUZYRA demonstrated efficacy against common pathogens in three Phase 3 studies, including pathogens resistant to other antibiotic classes as a potential best-in-class tetracycline

Shanghai , China , Taiwan , United-states , Hong-kong , Jing-zhang , Henan , Cambridge , Cambridgeshire , United-kingdom , Macau , Chinese